Live Breaking News & Updates on ஏறன் கோல்ட்பர்க்|Page 1

Stay updated with breaking news from ஏறன் கோல்ட்பர்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Panaxia Israel continues growth trend in the first quarter of 2021: reports record revenues of 19.7 million


 
 ( Panaxia Israel ) (TASE: PNAX),
 Israel s largest medical cannabis company and a global company with activity in Germany, France, Israel, Cyprus, Greece and Malta, today published its financial results for the first quarter of 2021.
Panaxia Israel - revenues in millions: 2019-2021 quarterly revenues
Dadi Segal, CEO of Panaxia Israel, said, We are delighted to cap another record quarter of strong growth in revenues, which for the first time include retail sales of Panaxia products in Germany and Cyprus, along with a significant decrease in operating and net losses. As the only company in Israel with EU-GMP certification from the EU Health Authority, which is required to export to Europe, Panaxia is currently focused on implementing its global strategy and a gradual shift to development, production and export of its brands to the premium markets that are characterized by high profitability and a small number of competitors, and on exclusive partnerships with ....

United States , Tel Aviv , Assi Rotbart , Dadi Segal , Segal Pharma Group , Eu Health Authority , Panaxia Group , Panaxia Pharmaceutical Industries , Panaxia Labs Israel Ltd , Tel Aviv Stock Exchange , Panaxia Global , Panaxia Labs Israel , Panaxia Israel , Labs Israel , Eran Goldberg , North America , Chronic Pain , Burn Treatment , ஒன்றுபட்டது மாநிலங்களில் , தொலைபேசி அவிவ் , டாடி ஸீகல் , ஸீகல் பார்மா குழு , தொலைபேசி அவிவ் ஸ்டாக் பரிமாற்றம் , ஆய்வகங்கள் இஸ்ரேல் , ஏறன் கோல்ட்பர்க் , வடக்கு அமெரிக்கா ,

Panaxia and Leriva announced: Exclusive collaborations in Greece


Share this article
Share this article
ATHENS and TEL AVIV, Israel, May 19, 2021 /PRNewswire/ Panaxia Labs Israel, Ltd. (Panaxia Israel) (TASE: PNAX), Israel s leading medical cannabis products manufacturer and Leriva Group, one of Greece s leading distributors of medical equipment, medical supplies and health services, announced today, Wednesday May 19, 2021, a binding agreement of manufacture, commercialization and distribution of medical cannabis finished products, developed by Panaxia for medical cannabis patients in Greece.
Under the agreement,
Panaxia will be responsible for registering the products, while complying with the European standard requirements, including EU-GMP; developing and manufacturing new and advanced products, including tablets, suppositories (candles) and inhalation products. ....

United States , Tel Aviv , Dadi Segal , George Joakimidis , Prnewswire Panaxia Labs Israel Ltd , Segal Pharma Group , Eu Health Authority , Panaxia Group , Panaxia Pharmaceutical Industries , Tel Aviv Stock Exchange , Leriva Group , Labs Israel , Panaxia Israel , Wednesday May , Neuropathic Pain , Cancerous Pain , European Standard , Eran Goldberg , Assi Rotbart , North America , Chronic Pain , Burn Treatment , ஒன்றுபட்டது மாநிலங்களில் , தொலைபேசி அவிவ் , டாடி ஸீகல் , ஸீகல் பார்மா குழு ,